Inclusion criteria |
Confirmed diagnosis of CHF based on ESC guidelines |
Symptoms corresponding to NYHA functional class II–IV |
AHA classification stages C–D |
LVEF ≤ 40 % |
Age ≥ 18 years |
Patient is discharged after being hospitalized for CHF within the last 12 months |
Patient is able to understand the German language |
Patient has sufficient eyesight to understand and follow the instructions communicated by Motiva® |
Patient is willing and able to use the required hardware and software and to maintain a patient diary |
Patient is residing within geographical reach of one of the ten telemonitoring centers in order to receive additional treatment if required as well as follow-up consultation |
Patient gives informed consent regarding benefits and risks related to the trial, and to sign a participation agreement for the installation of the home telemonitoring system Motiva® |
Exclusion criteria |
Myocardial infarction within the past 4 weeks |
Heart surgery or any coronary intervention within the past 8 weeks |
Cardiogenic shock within the past 4 weeks |
Intended cardiac surgery within the next 6 months or priority status on a waiting list for organ transplantation |
Severe chronic and pulmonary illness with an immediate impact on the main outcome measures |
Renal dysfunction requiring dialysis |
Dementia or other severe cognitive impairment |
Psychiatric disorders prohibiting a participation in the trial |
Patient is discharged to or living in an older persons clinic or a nursing home |
Patient is participating in another clinical trial |